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Abstract Recently people often suffer from unhealthy
energy metabolism balance as they tend to take more
energy than required. Normally, excess energy taken in is
converted into triglyceride and stored in adipocyte as lipid
droplets. Recent studies have suggested that irregular
accumulation of triglyceride in adipocyte might be a cause
of many metabolic diseases. Thus, the awareness of the
detrimental effects on health of excessive lipid droplets
accumulation (LDA) has urged the development or finding
of drugs to counter this effect, including those from
botanical origins. This review summarized recent progress
in this field from the viewpoint of crude drug studies with
references to their anti-LDA activity. Possible mechanisms
involved in their anti-LDA effect and isolations of the
relevant bioactive compounds were also discussed.
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Introduction
Excess energy taken into the body is to be stored in an
organelle, lipid droplets in the cells called adipocytes.Their
major physiological role is to function as reservoir of
energy [1]. Lipid droplets in adipocyte are always in a state
of flux, when the energy excess is in the surplus, energy is
converted into triglyceride, and when the energy is in short
supply, the stored triglyceride is re-converted into energy
[2]. Biologically, body lipid serves as body energy storage
and insulates us from low temperature. But, it can act as a
double edged sword [3]. This is because excessive storage
of lipid has been recently shown to be a cause of various
diseases including type-2 diabetes mellitus, cardiovascular
disease, and atherosclerosis [4, 5].
The possible detrimental effects on health of excessive
lipid droplets accumulation (LDA) have prompted the
search for counter measures, including studies of drugs
which reduce LDA. A natural product, berberine, has so far
been reported to reduce LDA in vivo via down-regulation
of peroxisome proliferator-activated receptor protein-c
(PPARc) [6, 7]. Apart from berberine, other examples of
plant-derived compounds with well-known anti-LDA
effect includes, genistein, curcumin, and (-)-epigalloca-
techin-3-gallate (EGCG) [8–10]. A long history of the use
of plant origin drugs by many nations resulted in the
widespread consumers’ perception that plant natural origin
drugs are safe or had fewer side effects.
Because of the knowledge of the importance of LDA in
adipocyte and that a few compounds isolated from plants
actually possess such an anti-LDA effect, researchers
studying plant natural products with anti-LDA are gaining
momentum recently. This review compiles information of
botanicals that have been or are being investigated for their
anti-LDA activity. Possible mechanisms involved in the
anti-LDA process and possible active compounds are also
included in this review.
Possible targets of anti-lipid droplets accumulation
agents
Extra energy is stored in specialized cells, adipocytes.
Adipocytes are grouped into two types, brown adipocytes
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and white adipocytes. Brown ones are mitochondria rich
and use energy whereas white ones store energy [3, 11, 12].
The differentiation process of white adipocytes from the
precursor cells and its LDA system could be a target in the
study to find LDA inhibition (Fig. 1).
Adipocytes originate from the same precursor stem cells
as chondrocytes, osteocytes and myocytes, known as
mesenchymal stem cells (MSCs) [13]. Differentiation ini-
tiates when the pluripotent MSCs receive signals from
extracellular stimulating factors such as bone morphoge-
netic proteins (BMPs), transforming growth factor-b (TGF-
b), activin, insulin-like growth factor 1 (IGF-1), interleu-
kin-17 (IL-17), and fibroblast growth factors (FGF) 1 and 2
[14–22]. It is also been well documented that a mixture of
3-isobutyl-1-methylxanthine (IBMX), dexamethasone
(DEX), and insulin (MDI inducer) stimulates the mouse
embryonic fibroblast cell line, 3T3–L1, to differentiate into
adipocytes in vitro [21]. Intensive studies on 3T3–L1
established that the presence of extracellular stimulating
factors rapidly caused expression of early adipogenic reg-
ulators, and CCAAT/enhancer-binding proteins (C/EBPs)
-b and -d. The expressions of C/EBPb and C/EBPd convey
the message from these extracellular stimulating factors to
activate the master regulators of adipogenesis, PPARc, and
C/EBPa. C/EBPb and -d were proved to be essential for the
expression of PPARc and C/EBPa, because the cells with
C/EBPb and -d knock out have down-regulated in PPARc
and C/EBPa expression. PPARc and C/EBPa operates in a
self-regulating positive feedback loop system. This feed-
back loop system increased expression of adipocyte-spe-
cific genes, which are important for the proper functioning
of adipocytes [22–31]. Such specific genes includes glu-
cose transporter type 4 (GLUT4), an insulin-regulated
glucose transporter protein that enables translocation to
plasma membrane to facilitate the uptake of glucose into
cells. This protein is expressed primarily in muscles and fat
tissues, which makes it an ideal marker for the determi-
nation of adipocyte differentiation [23]. In addition to
GLUT4, another lipid homeostasis-related gene, lipopro-
tein lipase (LPL) is also studied. LPL is an enzyme that
hydrolyzes triglycerides including very low-density lipo-
proteins (VLDL) into two free fatty acids and one mono-
acylglycerol molecule. It is mostly distributed in adipose,
heart, and skeletal muscle tissues [24]. The 11b-hydro-
xysteroid dehydrogenase type 1 (HSD11b1) is another
enzyme that is related to the metabolism, which is highly
expressed in adipose tissues. This family of enzymes cat-
alyzes the conversion of inactive cortisone to active cor-
tisol, and vice versa [25–27]. Fatty acid binding protein 4
(FABP4) also known as adipocyte protein 2 (aP2), is
Fig. 1 Simplified signaling cascade of lipogenesis and adipogenesis
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another adipocyte specific protein expressed primarily in
adipocyte that functions as a carrier protein [28]. The
lengthy process leading to adipogenesis might provide
numerous targets to be attacked for the inhibition of LDA.
All mammalian cells are known to contain some lipid
droplets [29], but the differentiated cells called white
and brown adipocytes possess larger sized lipid droplets
in higher numbers [30]. These lipid droplets consist of
neutral lipids, triacylglycerols and cholesterol esters
encased in a monolayer of phospholipid [1, 32]. The
esterified fat is on energy demand hydrolyzed to be used
as an energy source [3, 30]. Of the two types of adipo-
cytes, white ones generally contain larger lipid droplets
occupying a major part of the cytosol, whereas the brown
ones contain numerous and smaller lipid droplets. The
formations of lipids are catalyzed by the enzymes known
as acyl-CoA diglycerol acyltranferase (DGAT) and acyl-
CoA cholesterol acyltranferase (ACAT) [31–34].
Although the enzymes responsible for the lipid synthesis
are well-elucidated, the formation process of lipid
droplets is not clearly established. Two of the most likely
models are: (1) formation of tiny lipid droplets by DGAT
or AGAT, which are deposited between the membrane
leaflets of endoplasmic reticulum (ER), where the lipid
droplets gradually increase in size to finally ‘bud off’ the
ER, and (2) lipids accumulate between the luminal and
cytoplasmic membranes, which subsequently are
encapsulated by the membranes bilayer to formed lipid
droplets [31–33]. Apart from inhibiting the adipogenesis
process, anti-LDA effect may also be achieved by pre-
venting the adipocyte from accumulating lipid droplets.
As discussed before, inhibition of enzymes responsible
for the lipid formation may provide a tantalizing target
for inhibition of LDA. At present, since the exact
mechanisms of lipid droplets formation is still under
debate, future identification and understanding of the
mechanisms involved may provide new anti-LDA
targets.
During energy deprivation, lipid droplets stored in adipocyte
hydrolyze their content, triacylglycerols to fatty acids and
glycerol, under a process named lipolysis [35]. In addition to
the inhibition of lipid droplets synthesis, up-regulation of the
lipid metabolism or lipolysis process may also be effective in
lowering the adipocyte lipid droplets. Lipolysis is known to be
catalyzed by many enzymes generally called lipases, of which
adipose triglyceride lipase (ATGL or desnutrin) is known to
play a major role. The enzyme is responsible for some 75 %
adipocyte lipolysis [30, 34–36]. A study indicated that the first
step of lipolysis catalyzed by ATGL is the rate-limiting step, a
fact which emphasized the importance of ATGL in the lipol-
ysis [37]. Thus, inhibition of lipid droplets synthesis and pro-
motions of lipolysis of adipocyte lipid droplets equally function
to reduce LDA in adipocyte.
Plants investigated for anti-lipid droplets accumulation
activity
Inhibitors of adipogenesis or expression of adipogenic
factors
Aristolochia manshuriensis Kom—Aristolochiaceae
Aristolochia manshuriensis, a Korean traditional medicinal
herb is distributed in Japan, China, and Korea. Preliminary
studies showed that a stem extract of A. manshuriensis
down-regulates the gene expression of C/EBPb, PPARc,
and C/EBPa of 3T3–L1 cells. Further studies on the
upstream regulators of C/EBPb, PPARc, and C/EBPa led
to the conclusion that the extract disrupts the extracellular
signal-regulated protein kinase 1/2 (ERK1/2) and Akt
pathway leading to the inhibition of C/EBPb, PPARc, and
C/EBPa expression, which eventually leads to the inhibi-
tion of the adipocyte differentiation. In addition, gene
expression of fatty acid synthase (FAS), adiponectin, LPL,
and aP2 is also significantly down-regulated. In an in vitro
study, aristolochic acid (Fig. 2) isolated from the plant is
shown to be responsible for the inhibition of triglyceride
(TG) accumulation. Oral administration of a stem extract
of A. manshuriensis leaves at 62.5 mg/kg/day is reported to
significantly decrease the fat tissue weight, total cholesterol
(TC) level, and low density lipoprotein-cholesterol (LDL-
c) level of high-fat diet (HFD)-induced obesity mouse [38],
though it is yet not verified if such decreases are due to the
effect of aristolochic acid.
Brassica rapa (L.)—Brassicaceae
The roots of Brassica Rapa or commonly known as the
turnip are reported to contain licochalcone A (Fig. 3), a
major phenolic compound from the root of the Glycyrrhiza
plant, commonly known as licorice [39]. This compound
was found to suppress the differentiation of 3T3–L1 pre-
adipocytes. Further investigation showed that licochalcone
A significantly down-regulates the expression of PPARc,
Fig. 2 Structure of aristolochic acid
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C/EBPa, the sterol regulatory element-binding protein 1c
(SREBP-1c), and their target genes, FABP4, FAS, stearoyl-
CoA desaturase 1 (SCD1), and glycerol-3-phosphate
acyltransferase (GAPH). An in vivo study using ICR mice
fed with a high fat diet (HFD) showed that by adminis-
tration of licochalcone A at 10 mg/kg, the bodyweight and
the TG, TC, and non-esterified fatty acid (NEFA) levels
were significantly decreased by 14.0, 48.2, 58.9, and
73.5 %, respectively [40].
Camelia sinensis (L.) Kuntze—Theaceae
Leaves of Camelia sinensis, or the tea plant are most
commonly consumed in eastern Asia and Europe. Many
compounds have been isolated from tea leaves including
caffeine, (-)-epigallocatechin-3-gallate (EGCG) (Fig. 4),
and (-)-epi-catechin-3-gallate [9]. EGCG was demonstrated
to prevent adipogenesis and to cause adipocytes apoptosis,
though the details of its mechanism of action are not known
yet [41, 42]. In another study, the possible mechanism of
anti-adipogenesis by EGCG was reported, thus, by the real-
time PCR (RT-PCR) analysis of 3T3–L1 cells treated with
EGCG it was shown to decrease PPARc and C/EBPa
mRNA. Significant decrease in the forkhead transcription
factor class O1 (FoxO1) mRNA was also reported, which
suggested it to be via PI3-K (phosphoinositide 3-kinase)/
Akt and MEK [MAPK (mitogen-activated protein kinase)/
ERK (extracellular-signal-regulated kinase) kinase] path-
ways [43]. Many other papers also refer to the anti-obesity
effect of tea extract in in vivo studies [44–46].
Chisocheton ceramicus (Miq.) C. DC.—Meliaceae
Chisocheton ceramicus, known to be a source of hardwood
timber, is distributed in the tropical countries including
Malaysia, Indonesia, Brunei, Papua New Guinea, Philip-
pines and Vietnam. Like other plants of the Meliaceae, the
plant is rich in limonoids and a series of limonoids have been
isolated from the barks of this plant including the ceramicine
and chisomicine series, and 14-deoxyxyloccensin K [47–
53]. A bark extract of this plant was shown to possess an
anti-LDA activity on the mouse pre-adipocyte cell line,
MC3T3-G2/PA6 cells. Bioassay-guided separation of its
hexane soluble fraction led to the isolation of 12 limonoids,
ceramicines A–L, of which ceramicine B (Fig. 5) had the
most potent anti-LDA activity (IC50 = 1.8 lM). Structure–
activity relationship studies on ceramicines A–L and nine
ceramicine B derivatives indicated that the C-17 furan
moiety, C2–C3 double bond, and C14–C15 double bond
play important roles in eliciting the anti-LDA activity [54].
Subsequent studies on the protein and mRNA expression
suggested that the role ceramicine B in the anti-LDA activity
was to inhibit adipogenesis via suppression of PPARc
expression. Detailed studies on the upstream regulator of
PPARc indicated that ceramicine B interrupts phosphory-
lations of FoxO1 [55]. Phosphorylations of FoxO1 at Thr 24,
Ser 256, and Ser 319 are essential for advancement of adi-
pogenesis and unphosphorylated FoxO1 plays a role in the
repression of PPARc mRNA transcription [56, 57]. Thus
ceramicine B may be said to play an essential role in
inhibiting LDA by interrupting phosphorylations of FoxO1
which then leads to suppression of PPARc expression.
Lysimachia foenum-graecum Hance.—Primulaceae
Lysimachia foenum-graecum has been used traditionally as
an anti-inflammatory agent and also as a remedy for cold,
headache, and toothache. From the whole plant extract of L.
foenum-graecum, a series of triterpene saponin, foenumo-
side A-E and lysimachiagenoside A, C–F have been isolated
[58–61]. By a high-through put screening this plant was
Fig. 3 Structure of licochalcone A
Fig. 4 Structure of (-)-epigallocatechin-3-gallate (EGCG)
Fig. 5 Structure of ceramicine B
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demonstrated to suppress adipogenesis and this anti-adipo-
genesis activity was shown to be due to suppression of
PPARc, and C/EBPa protein expression in a concentration-
dependent manner, with IC50 at 2.5 lg/ml, which down-
regulate the downstream targets of PPARc, and C/EBPa,
aP2 and adiponectin [58]. Apart from the down-regulation of
the adipogenic marker gene, the whole plant extract of this
plant was also shown to suppress induction of gene
expression of lipogenesis related genes, FAS, SREBP-1c,
acetyl-CoA carboxylase (ACC), and SCD1. It is also to be
noted that the lipolytic genes were up-regulated, such as
acyl-CoA oxidase (ACO) and carnitine palmitoyltransferase
1 (CPT1). An in vivo study showed also that the body weight
of C57BL/6 mice fed with HFD decreased when treated with
L. foenum-graecum whole plant extract through oral-gavage
at 100 mg/kg. Foenumoside B (Fig. 6) was identified to be
responsible for the effect in both in vitro and in vivo studies.
It inhibited the differentiation of 3T3-L1 preadipocytes in a
dose-dependent manner with an IC50 of 0.2 lg/ml in the nile
red staining assay. In an in vivo assay, foenumoside B was
shown to suppress lipid accumulation in white adipose tis-
sues and in the liver, and to lower the blood levels of glucose,
triglycerides, alanine aminotransferase (ALT), and aspartate
aminotransferase (AST), in HFD-induced mice [62].
Magnolia denudata Desr.—Magnoliaceae
The hexane soluble fraction of an extract of Magnolia
denudata flowers was shown to inhibit gene expression of
PPARc and C/EBPa in 3T3–L1 cells without any observed
cytotoxicity. Four known lignans from the M. denudata
flower hexane soluble fraction, (?)-fargesin, (?)-eudes-
min, (?)-epimagnolin A, and (?)-magnolin (Fig. 7), were
examined for their anti-adipogenic property. At 50 lM,
there was an inhibitory effect of these lignans on the pro-
tein expression of PPARc, SREBP-1c, and C/EBPa. The
order of potency is (?)-epimagnolin A [ (?)-magno-
lin [ (?)-eudesmin [ (?)-fargesin [63].
Populus balsamifera (L.)—Salicaceae
Populus balsamifera or Balsam poplar is a medicinal plant
used by the natives of Canada as a possible anti-diabetic
remedy. Studies showed that a bark extract of this tree
showed that it possesses the ability to inhibit adipogenesis
and inhibits LDA in 3T3–L1 induced by MDI inducer.
More detailed studies using the PPARc reporter gene assay
indicated that its extract functions as an antagonist to
PPARc activity giving the max PPARc inhibition activity
of 87 %. Several compounds were identified in the P.
balsamifera, such as salicin and salicortin (Fig. 8), both
salicortin isomers showing complete inhibition of PPARc
activity [64]. Another study showed that both ethanolic, an
extract of P. balsamifera (250 or 125 mg/kg), and sali-
cortin (12.5 mg/kg) effectively and equally reduced the
accumulations of fat and liver TG in diet-induced obese
(DIO) C57BL/6 mice [65]. Other salicortin-derivatives
obtained from twigs of another plant of the same family
were shown to inhibit adipogenesis via modulation of the
C/EBPa and SREBP-1c dependent pathway (Table 1) [66].
Inhibitor of lipid droplets production or promoter
of lypolysis
Albizia julibrissin Durazz.—Fabaceae
Albizia julibrissin, used as a remedy for insomnia, amnesia,
sore throat, and contusions, is a native plant in Japan,
Fig. 6 Structure of foenumoside B
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China, and Korea. Studies showed that a 90 % aqueous
ethanol extract of A. julibrissin flowers inhibited TG
accumulation in the mouse fibroblastic cell line, 3T3–L1.
Bioassay-guided separation led to isolation of four flavanol
acylglycosides, 300-(E)-p-coumaroylquercitrin, 300-(E)-p-
feruloylquercitrin, 300-(E)-p-cinnamoylquercitrin, and 200-
(E)-p-cinnamoylquercitrin (Fig. 9). The bioactivity assay
of these four compounds was tested for the inhibition of
GPDH that converts glycerol into TG, and showed that 300-
(E)-p-coumaroylquercitrin was the most potent of the four
compounds to give 38.4 % inhibition of TG accumulation
in 3T3–L1 cells [98].
Citrus unshu Marcovitch—Rutaceae
Fruits of Citrus unshu or Citrus unshiu (Satsuma man-
darin orange)are known to contain an active ingredient, p-
synephrine (Fig. 10) [99]. Juice from unripen fruits of C.
unshu was reported to induce lipolysis in fat cells isolated
from male Wistar rats in a concentration-dependent
manner. To elucidate the mechanism involved in inducing
lipolysis by unripen C. unshu fruit juice, an aqueous
extract of lyophilized C. unshu fruit juice was added to
the isolated fat cells in the presence of b-blocker (inhib-
itor of lipolysis). Incubation with selective b1-antagonist
salicin salicortin
Fig. 8 Structures of salicin and salicortin
Fig. 7 Structures of (?)-fargesin, (?)-eudesmin, (?)-epimagnolin A, and (?)-magnolin
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(atenolol), b2-antagonist (IC118551), and b3-antagonist
(SR59230A) and non-selective b-blocker (propranolol),
indicated that an aqueous extract of C. unshu acts as a
non-selective b-agonist. Another in vivo study, also
showed that its aqueous extract increased lipolysis in rat
visceral (epididymal and omental) and subcutaneous
(abdominal and femoral) fat cells. Although p-synephrine
is reported to be the bio-active ingredient that induces
lipolysis, further studies are required to confirm this claim
[100]. In another study, C. unshu peel extract was found
to reduce as much as 50 % of perilipin, a lipid-associated
protein known to be secreted only in adipocytes, and to be
responsible for stabilizing lipid droplets. This fact may
indicate that C. unshu peel extract is related to the inhi-
bition of the formation of lipid droplets [31, 101]. Another
in vivo investigation reported that oral administration of a
major carotenoid compound from C. unshu peel, b-cryp-
toxanthin (Fig. 10), effectively reduces visceral adipose
tissue, body weight, and abdominal circumference of
Tsumura Suzuki Obese Diabetes (TSOD) mice [102].









Mechanism of action Ref. no.
Alpinia officinarum Hance
(Zingiberaceae)
Whole Galangin Inhibition of expression of PPARc, and C/EBPa,





Whole Aqueous extract Inhibition of expression of PPARc, and C/EBPa [68–70]
Clerodendron glandulosum
Coleb. (Verbenaceae)
Leaf Aqueous extract Inhibition of expression of PPARc, and subsequently
SREBP1c and FAS
[71, 72]




Inhibition of expression of PPARc, and C/EBPa, and




Rhizome Pseudoprotodioscin Inhibition of expression of PPARc, and C/EBPa,




Whole Fucosterol Inhibition of expression of PPARc and C/EBPa [76]
Evodia rutaecarpa (Juss.) Benth.
(Rutaceae)
Fruit Evodiamine Inhibition of adipogenesis via suppression of epidermal








Lecomte ex O’Rorke) Baill.
(Irvingiaceae)
Seed Extract Inhibition of expression of PPARc and reduction in
glyceraldehyde 3-phosphate dehydrogenase (G3PDH),
serum leptin, and increase in adiponectin
[81]
Lagerstroemia speciosa (L.) Per.
(Lythraceae)
Leaf Tannic acid Inhibit expression of PPARc [82–84]
Lindera erythrocarpa Makino
(Lauraceae)
Fruit Lucidone Inhibition of expression of PPARc and C/EBPa, and




Fruit Fruit juice Inhibition of expression of PPARc, SREBP-1c, and perillipin [86]




Inhibition of expression of PPARc, and C/EBPa,
subsequently FABP4 and FAS
[87–89]




Ethanol extract Inhibition of expression of PPARc, C/EBPa, and SREBP-1c [90]
Salacia reticulata Wight
(Celastraceae)
Whole Aqueous extract Inhibition of expression of PPARc, C/EBPa, and GPDH [91, 92]
Vigna nakashimae (Fabaceae) Seed Ethanol extract Inhibition of expression of PPARc via activation of
adenosine monophosphate (AMP)-activated protein kinase
(AMPK)
[93]
Vitis vinifera (L.) (Vitaceae) Seed Vitisin A Inhibition of expression of PPARc, and C/EBPa [94]
Wasabia japonica (Miq.)
Matsum. (Brassicaceae)
Leaf Aqueous extract Inhibition of PPARc, C/EBPa, SREBP-1c, and adiponectin [95, 96]
Zanthoxylum piperitum (L.) DC
(Rutaceae)
Fruit Ethanol extract Inhibition of expression of PPARc, C/EBPa, and SREBP-1c [97]
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Capsicum annuum (L.)—Solanaceae
Capsicum annuum, more commonly known as paprika or
red pepper, contains a well-known compound capsaisin
(Fig. 11). Water extract from C. annuum fruits was
recently shown to inhibit the action of LPL [103], a major
enzyme which reduces lipoprotein into monoacylglycerol
and free fatty acid [22]. Capsaisin is known to have an anti-
LDA effect via several suggested routes, including pro-
motion of thermogenesis and activation of AMPK [104,
105]. Another less well-known related compound of cap-
saisin, capsiate (Fig. 11), is also reported to increase
thermogenesis [106–108]. In addition to capsaisin and
capsiate, from a methanol extract of the fruit of C. annuum,
was isolated 9-oxooctadeca-10,12-dienoic acid (Fig. 11),
an inhibitor of ACC, an enzyme that carboxylates acetyl-
CoA into malonyl-CoA, an important precursor in the fatty
acid biosynthesis [109]. In addition to impairing the bio-
synthesis of lipid droplets, several studies also indicated
that a fruit extract of this plant possesses an anti-adipogenic
activity when tested by using 3T3-L1 cells [110, 111].
Coptis chinensis Franch.—Ranunculaceae
Coptis chinensis or Coptis japonica, is commonly known
as Huanglian in China, Ouren in Japan or Hwangryunha-
edok-tang in Korea. C. chinensis is well-known for con-
taining a yellow isoquinoline alkaloid, berberine (Fig. 12)
[112, 113]. Berberine itself is isolated from many other
plants and was previously suggested to be effective in the
treatment of cancer, diabetes, and obesity [114–119]. Its
use as an agent for treatment of diabetes and obesity might
have suggested the possible use of berberine as an anti-
LDA agent. Early in vitro and in vivo studies on the effect
of berberine indicated that it inhibits ACC, one of the key
lipogenesis enzymes which mediate activation of AMPK.
AMPK inhibits the ACC activity via phosphorylation of
ACC, as demonstrated in myoblasts and adipocyte in vitro
and also in db/db mice in vivo [120]. Similar results were
also reciprocated by another study, which reported a sim-
ilar result showing that berberine also causes activation of
AMPK in HepG2, the human hepatocellular carcinoma cell
line [121]. In addition to the inhibition of lipogenesis, the
anti-adipogenesis effect of berberine was also reported. In
summary, berberine has been shown to inhibit the expres-
sion of PPARc, and C/EBPa while up-regulating GATA
binding protein-2 (GATA-2) and -3 that functions as an
adipocyte differentiation suppressor [7, 122, 123].
Curcuma longa (L.)—Zingiberaceae
Curcuma longa, more commonly known as turmeric, is
cultivated in many parts of the tropical countries, from
the root of which a member of compounds have been
isolated, including curcumin, demethoxycurcumin and
Fig. 9 Stucture of 300-(E)-p-coumaroylquercitrin
Fig. 10 Structures of (±)-p-synephrine and b-cryptoxanthin
260 J Nat Med (2014) 68:253–266
123
bisdemethoxycurcumin (Fig. 13). Studies on the mixtures
of the above mentioned compounds have shown that in rats
fed with HFD, administration of such mixtures caused
reduction in the body weight gain and LDL-c [10]. In
another study, an ethyl acetate fraction from a C. longa root
methanol extract was shown to cause partial inhibition of
lipid synthesis in 3T3–L1 cells, which was suggested to be
via the suppression of GLUT4 expression and stimulation
of lipolysis via induction of hormone sensitive lipase
(HSL) and ATGL, where both lipases played a role as a
rate-limiting enzyme in a lipolysis process [124]. Further
investigations of those above mentioned, suggested lipol-
ysis activity may be mediated by curcumin. An in vivo
study showed that when added as a supplement to HFD at
500 mg/kg, curcumin itself caused the body weight
reduction of C57BL/6J mice. Further studies indicated that
when curcumin is administrated to C57BL/6J mice fed
with HFD at 500 mg/kg, it increased AMPK activity and
CPT1 expression while reducing glycerol-3-phosphate acyl
transferase-1. Thus, it causes increases in oxidation and
decreases in fatty acid esterification. Subsequent confir-
mation with RT-PCR, showed that curcumin also lowered
the expression of PPARc, and C/EBPa [125]. Investigation
by another researcher indicated that curcumin also reduced
the expression of PPARc, and C/EBPa in 3T3–L1 cells,
further supporting the hypothesis of curcumin influence on
PPARc, and C/EBPa expression [126]. Participation of the
Fig. 12 Structure of berberine
Fig. 11 Structures of capsaisin, capsiate, and 9-oxooctadeca-10,12-dienoic acid
Fig. 13 Structures of curcumin, demethoxycurcumin, and
bisdemethoxycurcumin
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Wnt signaling pathway in the curcumin-induced suppres-
sion of adipogenesis in 3T3–L1 cells was reported. Cur-
cumin was shown to dose dependently restored nuclear
translocation of b-catenin, a major component of Wnt
signaling, though the definite relationship between Wnt
signaling pathway and reduction in PPARc, and C/EBPa
expression remains unclear (Table 2) [127].
Conclusions
Concerns over various understandable health implications
possibly caused by excessive accumulation of lipid
droplets have stimulated studies in the search for anti-
LDA agents. However the body energy homeostasis sys-
tem is all too complex to allow easy solution to the
problem. This fact, in a way allows researchers to
approach this problem from various wider aspects. This
paper is a summary of such attempts from the plant
chemistry view point. Recent identification of several
plants and their contents showing significant potential
activity in inhibiting LDA both in vitro and in vivo has
been reported. Many studies are still conducted by using
crude extracts, but cases supporting their bioactive com-
pounds that are responsible for the expected activity are
isolated and, nevertheless, their mechanisms of action
involved have also been reported. As to date, the studies
on plant-derived anti-LDA agents are considered to be in
their early stages and more in-depth studies are necessary.
Nonetheless, from the plant chemistry viewpoint, plant
derived anti-LDA agents hold great potential to be
developed as a remedy for diseases caused by excessive
accumulation of lipid droplets in the future.
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